Back to Search Start Over

Molecular Dynamics Simulations and Experimental Results Provide Insight into Clinical Performance Differences between Sandimmune® and Neoral® Lipid-Based Formulations

Authors :
Colin W. Pouton
Shadabul Haque
Endri Kastrati
Vincent Jannin
Mitchell P. McInerney
David K. Chalmers
Karen M. Corbett
Christopher J.H. Porter
Leigh Ford
Hassan Benameur
Hywel David Williams
Dallas B. Warren
Source :
Pharmaceutical Research. 38:1531-1547
Publication Year :
2021
Publisher :
Springer Science and Business Media LLC, 2021.

Abstract

Molecular dynamics (MD) simulations provide an in silico method to study the structure of lipid-based formulations (LBFs) and the incorporation of poorly water-soluble drugs within such formulations. In order to validate the ability of MD to effectively model the properties of LBFs, this work investigates the well-known cyclosporine A formulations, Sandimmune® and Neoral®. Sandimmune® exhibits poor dispersibility and its absorption from the gastrointestinal tract is enhanced when administered after food, whereas Neoral® disperses comparatively well and shows no food effect. MD simulations were performed of both LBFs to investigate the differences observed in fasted and fed conditions. These conditions were also tested using an in vitro experimental model of dispersion and digestion. These MD simulations were able to show that the food effect observed for Sandimmune® can be explained by large changes in drug solubilization on addition of bile. In contrast, Neoral® is well dispersed in water or in simulated fasted conditions, and this dispersion is relatively unchanged on moving to fed conditions. These differences were confirmed using dispersion and digestion in vitro experimental model. The current data suggests that MD simulations are a potential method to model the fate of LBFs in the gastrointestinal tract, predict their dispersion and digestion, investigate behaviour of APIs within the formulations, and provide insights into the clinical performance of LBFs.

Details

ISSN :
1573904X and 07248741
Volume :
38
Database :
OpenAIRE
Journal :
Pharmaceutical Research
Accession number :
edsair.doi.dedup.....0808af6cfd8a6e523d490d015ec480b6